Figure 10 — LASSO regression and WGCNA-based telomerase-associated lncRNA signaling predicts clear cell renal cell carcinoma prognosis and immunotherapy response

Research Paper|Volume 16, Issue 11|pp. 9386–9409

LASSO regression and WGCNA-based telomerase-associated lncRNA signaling predicts clear cell renal cell carcinoma prognosis and immunotherapy response

Back to articleFigure 10(10 of 12)

100%

Figure 10.Drug sensitivity analysis. (A–C) Predicted sensitivity scores Dihydrorotenone, OF-1, and Wnt-C59 were candidates for chemotherapy in patients with high-risk scores. (D–F) Afutib, Cytarabine, and ERK6604 were candidates for chemotherapy in patients with high-risk scores. ^*p < 0.05; ^*p < 0.01; ^*p < 0.0001.